Press release
Cathepsin S (CTSS or EC 3.4.22.27) Market -Pipeline Review, H2 2017
About Cathepsin S Market
Cathepsin S (CTSS or EC 3.4.22.27) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 molecules are developed by Companies. The latest report Cathepsin S (CTSS or EC 3.4.22.27)-Pipeline Review, H2 2017, outlays comprehensive information on the Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
Cathepsin S (CTSS or EC 3.4.22.27)-Cathepsin S is a lysosomal enzyme that belongs to the papain family of cysteine proteases. Cathepsin S has a role in itch and pain, or nociception. The nociceptive activity results from cathepsin S functioning as a signaling molecule via activation of protease-activated receptors 2 and 4 members of the G-protein coupled receptor family. Cathepsin S has a physiological role outside the lysosome. Immune cells, including macrophages and microglia, secrete cathepsin S in response to inflammatory mediators including lipopolysaccharides, proinflammatory cytokines and neutrophils. The molecules developed by companies in Phase II, Phase I, Phase 0, Preclinical and Discovery stages are 1, 1, 1, 6 and 1 respectively. Report covers products from therapy areas Central Nervous System, Immunology, Gastrointestinal, Oncology, Infectious Disease, Metabolic Disorders and Musculoskeletal Disorders which include indications Neuropathic Pain, Rheumatoid Arthritis, Alzheimer's Disease, Autoimmune Disorders, Cancer Pain, Celiac Disease, Chagas Disease (American Trypanosomiasis), Colorectal Cancer, Crohn's Disease (Regional Enteritis), Diabetic Retinopathy, Liver Fibrosis, Lupus Nephritis, Osteoarthritis, Pancreatic Cancer, Primary Biliary Cirrhosis, Sicca Syndrome (Sjogren) and Systemic Lupus Erythematosus.
Request For Sample Report @ https://www.marketresearchreports.biz/sample/sample/1339576
Furthermore, this report also reviews key players involved in Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the global therapeutic landscape for Cathepsin S (CTSS or EC 3.4.22.27)
- The report reviews Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics and enlists all their major and minor projects
- The report assesses Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics
View Sample PDF @ https://www.marketresearchreports.biz/reports/1339576/cathepsin-s-ctss-or-ec-342227-pipeline-review-h2-2017-market-research-reports.pdf
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Cathepsin S (CTSS or EC 3.4.22.27)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Cathepsin S (CTSS or EC 3.4.22.27) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Cathepsin S (CTSS or EC 3.4.22.27)-Overview 6
Cathepsin S (CTSS or EC 3.4.22.27)-Therapeutics Development 7
Products under Development by Stage of Development 7
Products under Development by Therapy Area 8
Products under Development by Indication 9
Products under Development by Companies 10
Have Any Query? Ask Our Expert @
https://www.marketresearchreports.biz/sample/enquiry/1339576
Cathepsin S (CTSS or EC 3.4.22.27)-Therapeutics Assessment 12
Assessment by Mechanism of Action 12
Assessment by Route of Administration 13
Assessment by Molecule Type 14
Cathepsin S (CTSS or EC 3.4.22.27)-Companies Involved in Therapeutics Development 16
Amura Holdings Ltd 16
F. Hoffmann-La Roche Ltd 16
Fusion Antibodies Ltd 16
Sanofi 17
Virobay Inc 17
Cathepsin S (CTSS or EC 3.4.22.27)-Drug Profiles 19
AM-3840-Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
AM-3876-Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
Fsn-0503h-Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
RG-7625-Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
RO-5461111-Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
SAR-114137-Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
VBY-129-Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
VBY-285-Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
VBY-50365-Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
VBY-825-Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cathepsin S (CTSS or EC 3.4.22.27) Market -Pipeline Review, H2 2017 here
News-ID: 761833 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Cathepsin
Anti-Cathepsin B Industry Landscape and its Growth Prospect By 2020-2030
Anti-Cathepsin B Market: Introduction
Cathepsin B belongs to a family of lysosomal cysteine proteases. It plays an important role in intracellular proteolysis. In humans, Cathepsin B is encoded by the CTSB gene. Anti-Cathepsin B antibody is used to treat cancers, traumatic brain injuries, Ebola infection, and fertility issues.
Report Overview: https://www.transparencymarketresearch.com/anticathepsin-b-market.html
Key Drivers and Restraints of Global Anti-Cathepsin B Market
•Rise in incidence rate of cancer across the globe is a major…
Anti-Cathepsin B Market Seeking Growth from Emerging Markets, Views Sought On Ne …
The Anti-Cathepsin B Market report gives a weighty source to assess the market and other fundamental technicalities identifying with it. The examination unveils the total assessment and veritable parts of the Anti-Cathepsin B Market. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report.The trends and expected prospects for…
Anti-Cathepsin B Market to receive overwhelming hike in Revenues by 2029
Global Anti-Cathepsin B Market: Overview
Cathepsin B is an important mediator of inflammation and programmed cell death in individual cells. It has a role in inducing cell dissolution and recycling of cellular organelles. This organic molecule has been implicated in various cancers and other chronic conditions like Alzheimer’s disease and seizures, being primarily involved in the diminution of memory with progress of disease. Anti-Cathepsin B molecules are antibodies against Cathepsin B,…
Cathepsin K Inhibitors Therapeutics Pipeline Analysis 2019
Cathepsin K is a protease enzyme which is coded by CTSK gene. The function associated with the gene involves bone remodelling and resorption. Cathepsin K is a member of peptidase C1 protein family and expressed mainly in osteoclasts.
Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1176
The protein has high specificity for kinins and has the capability to catabolize collagen, elastin, and gelatin. Cathepsin K is found to be over-expressed in cancer such…
Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1)-Pipeline Revi …
A new report on “Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1)-Pipeline Review, H2 2017” offers information on the different clinical stages of Cathepsin B. The report, added to the vast repository of Market Research Hub (MRH) offers information and insights on the current scenario in development of Cathepsin B. A comprehensive source of information, the report provides detailed insights on the factors that are likely…
Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) Mar …
"The Latest Research Report Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Cathepsin L1 Market
According to the recently published report 'Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15)-Pipeline Review, H2 2017'; Cathepsin L1 (Cathepsin L or Major Excreted Protein or…
